In addition, suboptimal treatment of cardiovascular disorders after KT, related to under-utilization of angiotensin-converting-enzyme inhibitors and statins due to concerns of worsened allograft function could contribute to advanced arteriosclerosis and a higher mortality of relisted patients [7,34]. The gene discussed is ACE; the disease is arteriosclerosis.